Literature DB >> 4002292

Leishmaniasis in Bolivia. I. Lutzomyia longipalpis (Lutz & Neiva, 1912) as the vector of visceral leishmaniasis in Los Yungas.

F Le Pont, P Desjeux.   

Abstract

A relatively high leishmanial infection rate was found in the phlebotomine sandfly Lutzomyia longipalpis collected from three villages of the Los Yungas region (Department of La Paz, Bolivia). 2,578 female sandflies were dissected. In three houses surveyed in Santa Barbara promastigote infection rates of Lu. longipalpis were 4.2, 2.2 and 3.2% respectively. Anatomical localization of the infection in the insect, and biochemical characterization of the strains indicate that the parasite belongs to the Leishmania donovani complex. The geographical area and the biotopes of Lu. longipalpis are discussed in relation to the vector-parasite relationship.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4002292     DOI: 10.1016/0035-9203(85)90341-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  The first record of Lutzomyia longipalpis in the Argentine northwest.

Authors:  Andrea Gómez Bravo; María Gabriela Quintana; Marcelo Abril; Oscar Daniel Salomón
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

2.  Ecological niche modelling and predicted geographic distribution of Lutzomyia cruzi, vector of Leishmania infantum in South America.

Authors:  Everton Falcão de Oliveira; Eunice Aparecida Bianchi Galati; Alessandra Gutierrez de Oliveira; Elizabeth Ferreira Rangel; Bruno Moreira de Carvalho
Journal:  PLoS Negl Trop Dis       Date:  2018-07-30

3.  Detection of multiple circulating Leishmania species in Lutzomyia longipalpis in the city of Governador Valadares, southeastern Brazil.

Authors:  Mariana Santos Cardoso; Gabrielle Ariadine Bento; Laila Viana de Almeida; Joseane Camilla de Castro; João Luís Reis-Cunha; Vanessa de Araújo Barbosa; Cristian Ferreira de Souza; Reginaldo Peçanha Brazil; Hugo Oswaldo Valdivia; Daniella Castanheira Bartholomeu
Journal:  PLoS One       Date:  2019-02-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.